7Baggers
 Qualigen Therapeutics Rebrands to AIxCrypto Holdings  TipRanks Mon, 17 Nov 2025 11:36:23 GMT
 Qualigen Therapeutics Stockholders Approve All Proposals  GlobeNewswire Sun, 16 Nov 2025 21:10:00 GMT
 Qualigen Therapeutics, Inc. SEC 10-Q Report  TradingView Fri, 14 Nov 2025 22:23:01 GMT
 published on: 2025-11-11 06:18:10  newser.com Tue, 11 Nov 2025 12:18:10 GMT
 published on: 2025-11-06 06:10:46  newser.com Thu, 06 Nov 2025 12:10:46 GMT
 published on: 2025-11-05 23:41:18  newser.com Thu, 06 Nov 2025 05:41:18 GMT
 published on: 2025-11-04 03:58:09  newser.com Tue, 04 Nov 2025 09:58:09 GMT
 published on: 2025-11-03 08:42:41  newser.com Mon, 03 Nov 2025 14:42:41 GMT
 published on: 2025-11-02 21:07:13  newser.com Mon, 03 Nov 2025 02:07:13 GMT
 published on: 2025-11-02 07:20:20  newser.com Sun, 02 Nov 2025 12:20:20 GMT

Qualigen Therapeutics, Inc
(NASDAQ:QLGN) 

QLGN stock logo

Qualigen, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-...

Founded: 1996
CEO: Andrew Ritter  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends